Zusammenfassung
Übergänge fließend: Blasenmole (nicht maligne, geringe Trophoblastproliferation), Destruierende Mole (zunehmende Trophoblastproliferation, Invasion des Myometriums, hämatogene Aussaat in Vagina, Lunge), Plazentanaher Pseudotumor (Überschießende Gewebereaktion an der Implantationsstelle, keine Metastasen), Chorionkarzinom.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Azab M, Droz JP, Theodore C et al. (1989) Cisplatin, Vinblastine, and Bleomycin combination in the treatment of resistant high-risk-gestational trophoblastic tumors. Cancer 64: 1829–1832
Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS (1989) The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours ( GTT ). Br J Obstet Gynecol 96: 795–802
Bagshawe KD (1992) Trophoblastic tumors: Diagnostic methods, epidemiology, clinical features and management. In: Coppelson M (ed) Gynecologic Oncology. Churchill Livingstone, Edinburgh London Melbourne New York Tokyo, pp 1027–1043
Fasoli M, Ratti E, Franceschi S et al. (1982) Management of gestational trophoblastic disease: Results of a cooperative study. Obstet Gynecol 60: 205–209
Hammond CB, Borchert LG, Tyrey L et al. (1973) Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 115 (4): 451–457
Kashimura Y, Kashimura M, Sugimori H et al. (1986) Prophylatic chemotherapy for hydatidiform mole. Cancer 58: 624–629
Loehrer PJ Sr, Einhorn LH, Williams SD (1986) VP-16 plus Ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4: 528–536
Newlands ES, Bagshawe KD, Begent RHJ et al. (1986) Developments in chemotherapy for medium-and high-risk patients with gestational trophoblastic tumours (1979–1984). Br J Obstet Gynecol 93: 63–69
Petrilli ES, Morrow CP (1980) Actinomycin D toxicity in the treatment of trophoblastic disease. Gynecol Oncol 9: 18–22
Schmidt-Matthiesen H, Basted G (1993) Gynäkologische Onkologie. Schattauer, Stuttgart New York, pp 89–93
Smith EB, Weed JC, Tyrey L, Hammond CB (1982) Treatment of nonmetastatic gestational trophoblastic disease: results of Methotrexate alone versus Methotrexate-folinic acid. Am J Obstet Gynecol 144: 88–92
Soper JT, Clarke-Pearson D, Hammond CB (1988) Metastatic gestational trophoblastic disease: Prognostic factors in previously untreated patients. Obstet Gynecol 71 (3): 338–343
Soper JT, Hammond CB, Lewis JL Jr (1992) Gestational trophoblastic disease. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott, Philadelphia, pp 795–825
Theodore C, Azab M, Droz JP et al. (1989) Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposide. Cancer 64: 1824–1828
Wong LC, Choo YC, Ma HK (1985) Methotrexate with citrovorum factor rescue in gestational trophoblastic disease. Am J Obstet Gynecol 152: 59–62
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Bastert, G., Costa, S.D. (1993). Chorionkarzinom und destruierende Blasenmole. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_44
Download citation
DOI: https://doi.org/10.1007/978-3-662-10495-8_44
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56872-8
Online ISBN: 978-3-662-10495-8
eBook Packages: Springer Book Archive